Cantourage Group SE (XTER:HIGH) Beta: -0.0697 (As of Jun. 25, 2026)


XTER:HIGH Cantourage Group SE XTER:HIGH
22 GF Score
Price €6.04
! 4 Warning Signs
View Full Analysis

What is Cantourage Group SE Beta?

Cantourage Group SE XTER:HIGH -4.13% 22 Beta is -0.0697 as of Jun. 25, 2026. GuruFocus rates XTER:HIGH with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Cantourage Group SE's Beta is -0.0697.


Cantourage Group SE  (XTER:HIGH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cantourage Group SE Beta Related Terms


Cantourage Group SE Beta Historical Data

* Premium members only.

The historical data trend for Cantourage Group SE's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE Beta Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beta
0.00 0.00 0.00 0.00 0.00

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25
Beta Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

XTER:HIGH vs ZTS, UTHR, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Beta distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Beta falls into.


XTER:HIGH
22GF Score
Cantourage Group SE XTER:HIGH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantourage Group SE Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0697 mean?
Cantourage Group SE (XTER:HIGH) has a Beta of -0.0697 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cantourage Group SE and its competitors.
Is Cantourage Group SE's Beta too high?
Cantourage Group SE's current Beta is -0.0697. Overall, Cantourage Group SE has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Beta compare to ZTS and UTHR?
Cantourage Group SE's Beta of -0.0697 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cantourage Group SE and its competitors. Cantourage Group SE's current Beta is -0.0697. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Beta of -0.0697. The current Beta is -0.0697. Cantourage Group SE's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Beta is -0.0697 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantourage Group SE Business Description

Address Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
22GF Score

Get the complete analysis for XTER:HIGH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.04
Price